TickerFacts.

MaxCyte, Inc. (MXCT): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$47.56M
Year ended 2025-12-31
-$37.62M
Trailing 12 months to 2026-06-30
2019-12-31: -$11.81M2020-12-31: -$10.01M2021-12-31: -$16.76M2022-12-31: -$24.66M2023-12-31: -$44.13M2024-12-31: -$46.88M2025-12-31: -$47.56M-$47.56M
2019-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$47.56Mn/m2026-03-25, From 2025-01-01
2024-12-31-$46.88Mn/m2026-03-25, From 2024-01-01
2023-12-31-$44.13Mn/m2025-03-11, From 2023-01-01
2022-12-31-$24.66Mn/m2024-03-12, From 2022-01-01
2021-12-31-$16.76Mn/m2023-03-15, From 2021-01-01
2020-12-31-$10.01Mn/m2022-03-22, From 2020-01-01
2019-12-31-$11.81Mn/a2022-03-22, From 2019-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
MaxCyte, Inc. (MXCT)2025-12-31-$47.56Mn/m
OmniAb, Inc. (OABI)2025-12-31-$47.22Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$9.73Mn/m
NRC Health (NRC)2025-12-31$30.21M-26.7%
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$10.07Mn/m
Absci Corp (ABSI)2025-12-31-$108.58Mn/m
iSpecimen Inc. (ISPC)2025-12-31-$7.25Mn/m
OneMedNet Corp (ONMD)2025-12-31-$9.60Mn/m
Charles River Laboratories International, Inc. (CRL)2025-12-27$428.47M-27.3%

Compare MXCT, OABI, FOXO, NRC side by side · Screen every company in Services-Commercial Physical & Biological Research ↗